Review Of Trials Dispute Warning That Statins Impair Memory And Cognitive Functioning

The U.S. Food and Drug Administration recently warned that statins could affect the memory, attention span and other cognitive abilities of people who it drug to control high cholesterol. Despite cultural claims in the US that the FDA is too liberal in approval, a new review found that they were instead being far too conservative. It was the precautionary principle becoming a vice, according to a systematic review of 25 clinical trials incorporating nearly 47,000 people, led by Brian R. Ott, M.D., professor at the Alpert Medical School of Brown University. read more

Read the whole article on

More from